BioCentury
ARTICLE | Deals

Aug. 26 Quick Takes: Bolt, Innovent partner on non-traditional antibody conjugates

Plus ADC royalty deal, Sobi, Servier, DiCE IPO plans, AZ in Wilson’s and more

August 27, 2021 2:10 AM UTC

Bolt Biotherapeutics Inc. (NASDAQ:BOLT) and Innovent Biologics Inc. (HKEX:1801) announced a partnership to develop immune-stimulating antibody conjugates (ISACs) using Innovent’s mAb portfolio ...



Access this Article